Testing for SIBO: Diagnostic Approaches
Testing for SIBO should prioritize breath testing using combined hydrogen and methane analysis with glucose or lactulose as substrate, or alternatively, qualitative small bowel aspiration via upper endoscopy when breath testing is unavailable or inconclusive. 1
Primary Testing Methods
Breath Testing (First-Line)
The most recent 2025 British Society of Gastroenterology guidance recommends breath testing as the preferred non-invasive approach 1:
- Substrate options: Glucose or lactulose can be used, though both have limitations in accuracy 1
- Critical enhancement: Measuring both hydrogen AND methane significantly increases diagnostic accuracy compared to hydrogen alone 1
- When clearly positive, breath tests reliably indicate SIBO presence 1
Important nuances about breath testing:
- Glucose breath testing may provide greater accuracy than lactulose 2
- Some experts argue lactulose should be avoided entirely due to effects on small bowel transit and concerns about sensitivity/specificity 3, 4
- Diagnostic thresholds vary: Asia-Pacific criteria (≥12 ppm hydrogen rise) detect more cases with severe symptoms compared to North American criteria (≥20 ppm rise) 5
- Methane ≥10 ppm is considered positive and correlates with constipation-predominant symptoms 5
Small Bowel Aspiration (Alternative)
When breath testing is unavailable or results are equivocal, endoscopic aspiration provides direct diagnosis 1:
Qualitative assessment technique (preferred over quantitative due to ease) 1:
- Avoid aspirating on intubation
- Flush 100 mL sterile saline into duodenum
- Flush channel with 10 mL air
- Turn down suction
- Wait a few seconds
- Aspirate ≥10 mL into sterile trap
- Send to microbiology
- Positive aspirates will grow colonic bacteria 1
Key requirement: Establish agreement with local microbiology services beforehand for appropriate processing and reporting 1
Traditional quantitative aspiration (bacterial counts >10⁵/mL) is time-consuming and less practical 1, 6, though counts >10⁵/mL are considered clinically significant (normal <10⁴/mL) 6
When to Test vs. Empiric Treatment
The 2025 BSG guidance represents a shift from previous recommendations 1:
- Previous approach: Empirical antibiotic therapy for suspected SIBO
- Current recommendation: Testing rather than empirical treatment whenever possible to support antibiotic stewardship 1
- Rationale: Lack of response to empirical antibiotics may indicate resistant organisms, absence of SIBO, or coexisting disorders 1
Exception: Empiric treatment may be considered when no testing is available 1
Common Pitfalls to Avoid
Using breath tests in inappropriate populations: Not recommended for routine IBS testing without specific clinical suspicion 7
Relying on hydrogen-only testing: This misses methane-producing organisms and reduces sensitivity 1, 2
Testing after recent antibiotics: Ensure adequate washout period
Misinterpreting lactulose tests: May reflect rapid transit rather than true SIBO 3
Over-diagnosis: The widespread availability of breath testing has led to excessive SIBO diagnosis in patients with non-specific GI complaints 4, 8
Clinical Context Considerations
SIBO testing is most appropriate when:
- Symptoms include chronic diarrhea, bloating, abdominal pain, or malabsorption 1
- Risk factors present: post-surgical anatomy, strictures, fistulas, hypomotility, loss of ileocecal valve 3
- Intolerance to pancreatic enzyme replacement therapy (may indicate underlying SIBO) 1
Do not routinely test in typical IBS without specific risk factors or atypical features 7